{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T01:37:40Z","timestamp":1770601060322,"version":"3.49.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.vaccine.2006.11.008","type":"journal-article","created":{"date-parts":[[2006,11,22]],"date-time":"2006-11-22T15:22:48Z","timestamp":1164208968000},"page":"1806-1813","source":"Crossref","is-referenced-by-count":10,"title":["Safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated polio vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine"],"prefix":"10.1016","volume":"25","author":[{"given":"Susan","family":"Partridge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Alvey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Blatter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald","family":"Bottenfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Guerrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelly D.","family":"Senders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lode","family":"Schuerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Cheuvart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra J.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"51","key":"10.1016\/j.vaccine.2006.11.008_bib1","first-page":"Q1","article-title":"Recommended childhood and adolescent immunization schedule: United States, 2005","volume":"53","author":"Centers for Disease Control and Prevention","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2006.11.008_bib2","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0264-410X(00)00231-0","article-title":"A new DTPa\u2013HBV\u2013IPV vaccine co-administered with Hib, compared to a commercially available DTPw-IPV\/Hib vaccine co-administered with HBV, given at 6, 10 and 14 weeks following HBV at birth","volume":"19","author":"Gylca","year":"2000","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2006.11.008_bib3","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/00006454-200110000-00011","article-title":"Safety and immunogenicity of a pentavalent diphtheria, tetanus, pertussis, hepatitis B and polio combination vaccine in infants","volume":"20","author":"Yeh","year":"2001","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"10.1016\/j.vaccine.2006.11.008_bib4","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1542\/peds.109.4.e58","article-title":"Safety and reactogenicity of a novel DTPa\u2013HBV\u2013IPV combined vaccine given along with commercial Hib vaccines in comparison with separate concomitant administration of DTPa, Hib, and OPV vaccines in infants","volume":"109","author":"Zepp","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2006.11.008_bib5","doi-asserted-by":"crossref","unstructured":"Black S, Shinefield H, Fireman B, et al, and the Northern California Kaiser Permanente Vaccine Study Center Group. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 2000; 19(3):187-95.","DOI":"10.1097\/00006454-200003000-00003"},{"key":"10.1016\/j.vaccine.2006.11.008_bib6","doi-asserted-by":"crossref","unstructured":"Eskola J, Kilpi T, Palmu A, et al, for the Finnish Otitis Media Study Group. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 2001; 344(6):403-9.","DOI":"10.1056\/NEJM200102083440602"},{"issue":"1","key":"10.1016\/j.vaccine.2006.11.008_bib7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00006454-200301000-00006","article-title":"Impact of the pneumococcal conjugate vaccine on otitis media","volume":"22","author":"Fireman","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2006.11.008_bib8","doi-asserted-by":"crossref","unstructured":"Whitney CG, Farley MM, Hadler J, et al, for the Active Bacterial Core Surveillance of the Emerging Infections Program Network. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003; 348(18):1737-46.","DOI":"10.1056\/NEJMoa022823"},{"key":"10.1016\/j.vaccine.2006.11.008_bib9","unstructured":"Prevnar prescribing information. Philadelphia, PA: Wyeth Pharmaceuticals, Inc., 2005"},{"issue":"4","key":"10.1016\/j.vaccine.2006.11.008_bib10","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/biomet\/26.4.404","article-title":"The use of confidence or fiducial limits illustrated in the case of the binomial","volume":"26","author":"Clopper","year":"1934","journal-title":"Biometrika"},{"issue":"8","key":"10.1016\/j.vaccine.2006.11.008_bib11","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I","article-title":"Interval estimation for the difference between independent proportions: comparison of eleven methods","volume":"17","author":"Newcombe","year":"1998","journal-title":"Stat Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06012047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06012047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T12:57:46Z","timestamp":1555937866000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06012047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":11,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0264410X06012047"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.11.008","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}